Know Cancer

or
forgot password

Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor


N/A
18 Years
85 Years
Open (Enrolling)
Both
Leukemia, Monocytic, Acute

Thank you

Trial Information

Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor


Inclusion Criteria:



- Patients with AML in 1st & 2nd complete remission w/no HLA matched related donor

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Efficacy

Outcome Time Frame:

2009-2015

Safety Issue:

No

Principal Investigator

Fahad AlMohareb

Investigator Role:

Principal Investigator

Investigator Affiliation:

KFSH&RC

Authority:

ORA: KFSH&RC, Riyadh, Saudi Arabia

Study ID:

RAC#2001-004

NCT ID:

NCT00531583

Start Date:

March 2001

Completion Date:

June 2015

Related Keywords:

  • Leukemia, Monocytic, Acute
  • AML in 1st & 2nd complete remission w/no HLA matched related donor
  • Leukemia
  • Leukemia, Monocytic, Acute

Name

Location